Clinical Trials Directory

Trials / Completed

CompletedNCT00579865

Quality Of Life in Patients With Malignant Biliary Obstruction

Impact of Biliary Drainage on Quality Of Life in Patients With Malignant Biliary Obstruction

Status
Completed
Phase
Study type
Observational
Enrollment
124 (actual)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

You may have symptoms like itching, abdominal pain, loss of appetite, fatigue, fevers and chills. The treatment you will receive to relieve the blockage is also intended to relieve symptoms and improve your quality of life. The purpose of this study is to find out if relieving the blockage in your bile duct improves your quality of life.

Detailed description

Malignant biliary obstruction (MBO) may arise in patients with cholangiocarcinoma, pancreatic carcinoma, primary gallbladder carcinoma, hepatocellular carcinoma, or metastatic disease to the liver or portal lymph nodes. MBO is often accompanied by significant symptoms that may result in impairment of health-related quality of life (HRQL), including pruritus, fever, nutritional deficits, abdominal pain, nausea and vomiting, and fatigue. Approaches to the relief of MBO include surgical bypass and/or resection, percutaneous drainage with or without biliary stenting, or endoscopic stenting. The non surgical procedures may be done prior to attempted curative resection or for palliation in individuals with unresectable or recurrent disease.

Conditions

Interventions

TypeNameDescription
BEHAVIORALquestionnairescomplete the FACT-Hep, the SSQ, and the Visual Analog Scale for Pruritus Assessment at 1 week and 4 weeks post procedure.
BEHAVIORALquestionnairescomplete the FACT-Hep, the SSQ, and the Visual Analog Scale for Pruritus Assessment at 1 week and 4 weeks post procedure. Patients who have undergone bypass or resection will complete an additional set of questionnaires at 9 and 14 weeks.

Timeline

Start date
2005-05-01
Primary completion
2010-01-01
Completion
2010-01-01
First posted
2007-12-24
Last updated
2010-01-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00579865. Inclusion in this directory is not an endorsement.